CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 46 filers reported holding CIDARA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $12,625 | -36.2% | 13,400 | -23.4% | 0.00% | – |
Q2 2023 | $19,775 | -63.3% | 17,500 | -58.7% | 0.00% | – |
Q1 2023 | $53,848 | -79.4% | 42,400 | -87.7% | 0.00% | – |
Q4 2022 | $261,008 | +1907.8% | 345,112 | +1625.6% | 0.00% | – |
Q3 2022 | $13,000 | -53.6% | 20,000 | -65.1% | 0.00% | – |
Q2 2022 | $28,000 | +47.4% | 57,350 | +151.5% | 0.00% | – |
Q1 2022 | $19,000 | -89.3% | 22,800 | -83.7% | 0.00% | – |
Q4 2021 | $178,000 | +114.5% | 139,785 | +277.4% | 0.00% | – |
Q3 2021 | $83,000 | +219.2% | 37,041 | +187.9% | 0.00% | – |
Q2 2021 | $26,000 | -54.4% | 12,865 | -39.7% | 0.00% | – |
Q1 2021 | $57,000 | +119.2% | 21,336 | +104.5% | 0.00% | – |
Q1 2020 | $26,000 | -64.9% | 10,433 | -46.2% | 0.00% | – |
Q4 2019 | $74,000 | +25.4% | 19,396 | +32.6% | 0.00% | – |
Q1 2018 | $59,000 | -54.3% | 14,631 | -14.6% | 0.00% | – |
Q2 2017 | $129,000 | -58.4% | 17,137 | -29.7% | 0.00% | – |
Q3 2015 | $310,000 | -4.6% | 24,391 | +5.1% | 0.00% | – |
Q2 2015 | $325,000 | – | 23,207 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,677,194 | $819,000 | 1.02% |
BVF INC/IL | 6,861,127 | $3,352,000 | 0.16% |
5AM Venture Management, LLC | 1,134,511 | $554,000 | 0.14% |
Knott David M Jr | 635,254 | $310,000 | 0.13% |
Nantahala Capital Management | 4,819,090 | $2,355,000 | 0.12% |
West Family Investments, Inc. | 368,910 | $180,000 | 0.07% |
Stonepine Capital Management, LLC | 208,443 | $102,000 | 0.05% |
JEPPSON WEALTH MANAGEMENT, LLC | 181,075 | $88,000 | 0.04% |
Ground Swell Capital, LLC | 11,397 | $6,000 | 0.01% |
Point72 Asset Management, L.P. | 4,200,000 | $2,052,000 | 0.01% |